Collins Cooper C.

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$1.87M
Insider Sells Quantity
1
Insider Sells Sum
$9.21M

Insider Activity of Collins Cooper C.

According to the SEC Form 4 filings, Collins Cooper C., being in a position of

  1. director at TherapeuticsMD, Inc.,
    оver the last 12 months, has bought 5294 shares for $9,138, and sold 0 shares,
    over all time since 2013-06-14, has bought 2181294 shares for $1.87M, and sold 5263158 shares for $9.21M.

The largest purchase of all time was on 2021-08-18 and amounted to 900000 shares of TherapeuticsMD, Inc. for $648,000.

The largest sale of all time was on 2013-06-14 and amounted to 5263158 shares of TherapeuticsMD, Inc. for $9.21M.

Biography of Collins Cooper C.

No biography is available at this moment.

2024-08-22PurchaseTherapeuticsMD, Inc.
TXMD
director
4,094
0.0352%
$1.73$7,099-6.29%
2024-08-21PurchaseTherapeuticsMD, Inc.
TXMD
director
1,200
0.0105%
$1.70$2,039-2.96%
2021-11-18PurchaseTherapeuticsMD, Inc.
TXMD
director
1M
0.0046%
$0.58$578,500-65.74%
2021-08-18PurchaseTherapeuticsMD, Inc.
TXMD
director
900,000
0.0043%
$0.72$648,000-54.17%
2021-08-17PurchaseTherapeuticsMD, Inc.
TXMD
director
100,000
0.0005%
$0.77$77,000-56.49%
2020-06-08PurchaseTherapeuticsMD, Inc.
TXMD
director
74,000
0.0005%
$1.45$107,300-8.05%
2019-05-13PurchaseTherapeuticsMD, Inc.
TXMD
director
30,000
0.0003%
$3.33$99,870-24.24%
2016-03-11PurchaseTherapeuticsMD, Inc.
TXMD
director
32,000
0.0003%
$6.23$199,434-0.44%
2014-06-05PurchaseTherapeuticsMD, Inc.
TXMD
director
40,000
0.0005%
$3.84$153,780+18.78%
2013-06-14SaleTherapeuticsMD, Inc.
TXMD
director
5.26M
0.0497%
$1.75$9.21M+50.18%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.